WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Dennis SlamonDirector2024-03-189,510$83.81
$797.03kSell
Erin BurkhartGVP Chief Accounting Officer2024-03-18372$83.87
$31.20kSell
Dennis SlamonDirector2024-03-1810,000$79.70
$797.00kBuy
Henry J. FuchsPresident Worldwide RD2024-03-1533,485$83.87
$2.81MSell
Jean Jacques BienaimeDirector2024-03-1585,209$83.87
$7.15MSell
Brian MuellerEVP Chief Financial Officer2024-03-1520,789$83.87
$1.74MSell
Jeffrey Robert AjerEVP Chief Commercial Officer2024-03-1522,580$83.87
$1.89MSell
Charles Greg GuyerEVP Chief Technical Officer2024-03-1520,424$83.87
$1.71MSell
George Eric DavisEVP Chief Legal Officer2024-03-1521,699$83.87
$1.82MSell
Jean Jacques BienaimeDirector2024-03-061,000$86.71
$86.71kSell

1 of 7

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Primecap Management Co9.76%18,414,374$1.62BInstitution
Vanguard Group Inc9.57%18,050,062$1.58BInstitution
Blackrock Inc7.78%14,681,644$1.29BInstitution
Dodge Cox7.42%13,994,063$1.23BInstitution
Capital Research Global Investors5.71%10,774,641$945.37MInstitution
State Street Corp3.57%6,730,515$590.54MInstitution
Ameriprise Financial Inc2.87%5,419,366$475.50MInstitution
Barclays PLC2.80%5,288,893$464.05MInstitution
Viking Global Investors LP2.59%4,889,454$429.00MInstitution
Avoro Capital Advisors LLC2.28%4,300,000$377.28MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN98.08%1.64%Net SellingNet Selling
BGNE3.31%34.71%Net SellingNet Selling
RPRX51.02%16.51%Net SellingNet Selling
ALNY80.88%19.12%Net SellingNet Selling
GMAB70.53%0.00%

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 98.08% institutional shareholders, 1.64% Biomarin Pharmaceutical insiders, and 0.28% retail investors. Primecap Management Co is the largest individual Biomarin Pharmaceutical shareholder, owning 18.41M shares representing 9.76% of the company. Primecap Management Co's Biomarin Pharmaceutical shares are currently valued at $1.63B.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.